SELF-TEST FOR SARS-COV-2 ANTIGEN (CORONAVIRUS) - ANVISA Registration 80537410106

Access comprehensive regulatory information for SELF-TEST FOR SARS-COV-2 ANTIGEN (CORONAVIRUS) in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 80537410106 and manufactured by manufacturer not specified. The registration is held by CELER BIOTECNOLOGIA S/A with validity until Mar 28, 2032.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including HANGZHOU ALLTEST BIOTECH CO. LTD, GENRUI BIOTECH INC., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
80537410106
2 Related Devices
Registration Details
ANVISA Registration Number: 80537410106
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Related Devices (2)

Registration Details

80537410106

25351052657202217

04846613000103

Company Information

Dates and Status

Mar 28, 2022

28/03/2032

09/18/2025 19:00:01

Registration Details

80537410106

25351052657202217

04846613000103

Company Information

China
PT: CHINA, REPÚBLICA POPULAR

Dates and Status

Mar 28, 2022

28/03/2032

09/18/2025 19:00:01